|
“The accelerating global
recognition of Inflexal® V,
the market opportunities it
has created for us and our
partners and its emergence
as one of the purest and
most efficacious Influenza
vaccines has made it one
of the most promising
products of this decade."
Dr. Jaap Goudsmit
Key speaker at the symposium
|
Crucell marked the 10th anniversary of Inflexal® V, its virosome-adjuvanted influenza vaccine. For this reason a two-day symposium has been lined up in Bern, Switzerland on Thursday 26th of April as part of the commemorations.
During the symposium on Inflexal® V, each speaker will reflect on two perspectives:
-
10 years back: Where we are coming from in the field of Influenza, having full knowledge of who should be vaccinated, understanding the technologies as well as the development and utilization of flu-based vaccines?
One of the key speakers at the symposium includes Crucell’s Chief Scientific Officer Dr. Jaap Goudsmit.
Click here for the detailed agenda of the symposium.
|
Home